DocDollars

Hoffmann-La Roche Limited

Canada · Reporting entity ID 100000005726

Total reported 2019–2025
$105.8M
#89 of 2,960 reporting companies — 0.1% of all reported industry payments
$1.18M in general payments across 966 records, plus $104.7M in research funding across 9,200 records.

How it breaks down

General payments $1,183,884
Research funding $104,658,035

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Hoffmann-La Roche Limited reported $105.8M to US doctors and teaching hospitals from 2019 to 2025, ranking #89 of 2,960 reporting companies. 99% of that was research funding and 1% general payments such as consulting, speaking, food and travel. 966 general payment records and 9,200 research records were filed.

Common questions about Hoffmann-La Roche Limited

How much has Hoffmann-La Roche Limited paid US doctors?

Hoffmann-La Roche Limited reported $105,841,919 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $1,183,884 in general payments, $104,658,035 in research funding.

How does Hoffmann-La Roche Limited rank among drug and device companies?

It ranks #89 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Hoffmann-La Roche Limited mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.